femoxetine

This page covers all femoxetine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 1A, D(2) dopamine receptor, Histamine H1 receptor.

Targets

5-hydroxytryptamine receptor 1A, D(2) dopamine receptor, Histamine H1 receptor

Phase 2 pipeline (1)

• FEMOXETINE · Neuroscience
  Femoxetine works by blocking the reuptake of serotonin, allowing more of this neurotransmitter to be available in the brain.

Patent intelligence

• femoxetine patent landscape — aggregated cliff calendar, attackable patents, originator estates